Novo chairman to step down in board rift over pace of change
NegativeFinancial Markets

Novo Nordisk's chairman is stepping down amid a significant board rift regarding the pace of change within the company. This decision comes as part of a broader shakeup, with over half of the board members expected to leave. This situation is crucial as it may impact the company's strategic direction and the future of its popular weight-loss drugs, Wegovy and Ozempic, which have been pivotal in the market.
— Curated by the World Pulse Now AI Editorial System